Longs Drug Stores Corporation (NYSE: LDG) is doing something which may seem odd to many, which is essentially a "going with the bird in the hand" strategy. The company has just announced that its board of directors has determined not to have buyout discussions with Walgreens (NYSE: WAG). This was after consultation with its legal and financial advisors. Walgreens had sent Longs an expression of interest that was announced on September 12.
Longs Drug Stores Corporation (NYSE: LDG) is trading way up this morning after last night’s announcement that CVS Caremark Corporation (NYSE: CVS) will acquire the company. In a definitive agreement reached, Longs will receive $71.50 per share in cash in the buyout. After the assumption of debt and items, this buyout is valued at roughly $2.9 Billion.
Analyst coverage is looking pretty thin on individual calls this morning, but here are ten of the analyst calls we are looking at this Thursday morning:
Jon C. Ogg
May 15, 2008